Press "Enter" to skip to content

Still COVIDing Canada Posts

A 19-year-old athlete now spends his days bedridden because of long COVID

Struck down by long COVID for the past year, a great athlete and CEGEP student remains hopeful even if he has to spend his days lying down doing nothing, because the slightest effort completely exhausts him.

“Deep down, I think I’ll heal completely, but it’s going to take time. I trust science,” says Ludovic Bégin, with a weak voice on the other end of the line.

Comments closed
Featured

International Long COVID Awareness Day 2025

International Long COVID Awareness Day – COVID-cautious walk

Date: Saturday, March 15, 2025

Time: 7 pm – 8 pm

Where: Ottawa City Hall (meet at the entrance, Laurier Avenue side)

Join us for a walk on International Long COVID Awareness Day, Saturday, March 15, 2025 at 7 pm. The route is wheelchair-accessible.

Comments closed

Another 100 new long COVID cases each month

The Québec network of clinics for long COVID still receives, each month, a hundred new patients, who sometimes have to wait up to six months before they can be treated.

“The problem now is that we have an accumulation of complex cases. It’s difficult to get new cases into treatment because we can’t finish with some patients,” says Simon Décary, Chair of the Long COVID Clinics Steering Committee.

Around 5% of people who contract COVID will still experience sequelae between three months and one year after infection. And around 1% of the population will have severe functional limitations to the point of needing services, says the physiotherapist.

Comments closed

Federal government cancels deal with US company to make COVID-19 vaccine in Montreal

The federal government has cancelled a deal with vaccine maker Novavax to manufacture COVID-19 vaccine in Montreal, the company said in a filing with the U.S. securities regulator.

Novavax told the Securities and Exchange Commission that the Canadian government cancelled the deal March 7 after the company failed to meet a Dec. 31, 2024 deadline to get regulatory approval for a COVID-19 vaccine using ingredients made at the federally-owned Biologics Manufacturing Centre in Montreal.

Comments closed

Long COVID, “is it going to be like this for the rest of my life?”

Five years after COVID-19 disrupted the daily lives of many people in the country, some are still dealing with the lingering after-effects of this virus, whose symptoms are most often similar to those of the flu and fade after a few days. For Marie-Noëlle Claveau, the effects of long COVID persist, years later.

The singing professor and coordinator of the music program at Collège d’Alma has been dealing with the consequences of this disease since November 2023. Since then, she has been on sick leave and is being monitored at the long COVID clinic at the Jonquière Hospital.

“Let’s just say that the years 2023 and 2024 were quite difficult, but I can say that progress continues to be made slowly but surely,” says Marie-Noëlle Claveau.

Comments closed

Lives on hold: Thousands of Quebecers suffering from long COVID five years after pandemic began

Roxanne Major was working as an auxiliary nurse in a seniors’ residence two years ago when a COVID-19 outbreak spread through the home, infecting staff and residents.

Asked to replace a colleague who fell ill, Major took extra precautions. She disinfected her medication cart three times and wore a mask, full gown, gloves and protective glasses.

Despite her efforts, Major soon tested positive herself. Following a brief attempt to return to work the next week — the dizziness and exhaustion were too much — she was granted 10 days off to recover.

Two years later, Major, 40, has yet to return to the job she loved for 19 years. As she said in a recent interview, “everything went upside down.”

Comments closed

Made-at-McMaster inhaled COVID-19 vaccine begins phase-2 human trial

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

The AeroVax study, supported by $8M in funding from the Canadian Institutes of Health Research (CIHR), will test needle-free vaccines developed to provide protection from SARS-CoV-2.

Led by Fiona Smaill and Zhou Xing, members of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster, the multi-centre trial will evaluate the new vaccine in a broad study group, while also confirming safety.

Comments closed

Life has gone back to normal. But those with long COVID continue to suffer

When Nathanael Rafinejad first moved to Montreal, they loved the city’s nightlife and worked as a bartender and a waiter while studying business management.

But after catching COVID-19 in January 2022, the 29-year-old is now mostly confined to their apartment.

“I feel completely cut off from the world most of the time,” said Rafinejad. “I can’t walk anymore. I cannot stand for more than a few seconds at a time. I can’t sit for a long time. I have to use a wheelchair every day.”

Comments closed

Seeing your life turned upside down

To illustrate her long journey through long COVID, Dr. Anne Bhéreur shows me a photo sent to her by her friend Julie Pinard, who also suffers from a severe form of the disease. It shows the ice of the river at Kamouraska, sparkling in a thousand pieces under a winter sun. In the distance, fog. On the other bank, Mont des Éboulements.

The photo captures what Dr. Bhéreur has been going through since she was infected with COVID-19. It was in December 2020, following an outbreak in the palliative care setting where she worked. The doctor, a mother in her forties with no medical history and boundless energy, was convinced that she would return to her old life after 10 days. More than four years later, while she is still living with serious after-effects of the disease, she is beginning to come to terms with the idea that this life may not come back.

Comments closed

‘Get in Dorks’: Stand Up for Science rallies spread to 32 U.S. cities

Since Donald Trump took office in January, researchers across the U.S. have been waiting for scientific leaders to forcefully speak out against the administration’s grant freezes, research funding cuts, and targeting of diversity in their field. Frustrated that there seemed to be no large-scale movement coalescing, Colette Delawalla, a graduate student in clinical psychology, took matters into her own hands.

She posted on Bluesky, now the social media of choice for many scientists, “Get in Dorks, we are going protesting.” At the time, “I really thought 500 people might show up to D.C., that’s where I was in my head,” she said.

But little more than three weeks later, what began as an effort by five early-career researchers has exploded into a global movement called Stand Up for Science — with 32 coordinated rallies planned across the country on Friday, and affiliated walkouts and protests across the globe. The largest events are slated for Washington D.C., New York City, and Boston.

Comments closed

The measles epidemic continues in Quebec with 30 confirmed cases now

The measles epidemic continues in Quebec. The province has reached 30 cases, according to the most recent figures from Public Health.

The Laurentides region remains the most affected with 27 cases of measles, the others being in the territories of Montreal, Laval and Montérégie.

Comments closed

‘We’re losing decades of our life to this illness’: long Covid patients on the fear of being forgotten

Five years on from March 2020, millions of people still face debilitating symptoms, with huge repercussions on public health and productivity. But politicians are starting to pretend the pandemic never happened

On 20 March 2020, Rowan Brown started to feel a tickle at the back of her throat. Over the next few days, new symptoms began to emerge: difficulty breathing, some tiredness. By the following week, the UK had been put under lockdown in a last-minute attempt to contain the spread of SARS-CoV-2, or Covid-19. No one else she knew had yet been infected, so she posted updates on Facebook to keep people informed: “Oh, guys, it feels like a mild flu. Tonsillitis was definitely worse.”

Brown didn’t know then she was at the beginning of a condition that did not yet have a name, but which has since become known as long Covid. After two weeks, she had a Zoom with a friend, and at the end of the conversation it was as if all life force had drained out of her body. Her doctor advised her to stay in bed for two weeks. Those two weeks turned into three and a half months of extended Covid symptoms: nausea, fevers, night sweats, intense muscle and joint pain, allodynia (a heightened sensitivity to pain), hallucinations, visual disturbances. By the end of the three months, she had noted 32 different symptoms. “I didn’t recognise the way my body felt at all: my skin, my hair,” she remembers now. “It was like being taken over by a weird alien virus, which I guess is what happened.”

Comments closed

Increased mortality and serious health issues for those hospitalised with COVID, study reveals

In short

International research has shown an increased risk of further hospitalisation and death among those who were hospitalised for COVID-19.

The first six months following infection showed the largest difference, with the excess risk of death almost tripling.

The study showed risk decreased over time, but remained elevated more than two years after infection.

Comments closed

Measles cases in Ontario have nearly doubled over the last 2 weeks

This is a corrected story. A previous version from The Canadian Press erroneously reported that there were 84 new measles cases reported in Ontario over the last two weeks when in fact there were 78.

Ontario is reporting 78 new measles cases over the last two weeks, nearly doubling the province’s total count since an outbreak started in the autumn.

Comments closed

Manitoba becomes first province to join national pharmacare program with $219M deal

OTTAWA – Manitoba became the first province to officially join Ottawa’s pharmacare program on Thursday, giving it access to federal funding to cover the cost of birth control and diabetes medications as well as hormone replacement therapy for menopause.

Comments closed

The Trump years will be grim for long Covid sufferers

In December 2020, the U.S. government’s involvement in addressing the pandemic of long Covid officially began when Congress allocated $1.15 billion to the National Institutes of Health for research into the lasting health consequences of Covid-19. For people suffering from long Covid, the move offered hope.

Just over four years later, on Feb. 19, President Trump disbanded the Health and Human Services Secretary’s Advisory Committee on Long COVID, as part of an executive order titled “Commencing the Reduction of the Federal Bureaucracy.” After the Biden administration’s tepid involvement and fitful progress in long Covid policy and practice, this decision may signal the end of meaningful federal involvement in mitigating the plight of millions of long Covid sufferers.

Comments closed

A Texas child who was not vaccinated has died of measles, a first for the US in a decade

LUBBOCK, Texas (AP) — A child who wasn’t vaccinated died in a measles outbreak in rural West Texas, state officials said Wednesday, the first U.S. death from the highly contagious — but preventable — respiratory disease since 2015.

The school-aged child had been hospitalized and died Tuesday night amid the widespread outbreak, Texas’ largest in nearly 30 years. Since it began last month, a rash of 124 cases has erupted across nine counties.

The Texas Department of State Health Services and Lubbock health officials confirmed the death to The Associated Press. The child wasn’t identified but was treated at Covenant Children’s Hospital in Lubbock, though the facility noted the patient didn’t live in Lubbock County.

Comments closed

F.D.A. Cancels Meeting of Vaccine Experts Scheduled to Advise on Flu Shots

A panel of scientific experts that advises the Food and Drug Administration on vaccine policy — and that has been the target of criticism from Health Secretary Robert F. Kennedy Jr. — learned on Wednesday that its upcoming meeting to discuss next year’s flu vaccines had been canceled.

The F.D.A. sent an email to members of the panel, the Vaccines and Related Biological Products Advisory Committee, on Monday afternoon informing them of the cancellation, according to a senior official familiar with the decision. There was no reason given. The panel was to meet on March 13.

Comments closed